Issues around the definitions and severity of pandemic influenza

Recommendation by the European Medicines Agency concerning Pandemrix vaccination and reports of narcolepsy in children and adolescents

Case inventory study from Sweden concerning association of Pandemrix vaccination and reports of narcolepsy with cataplexy in children and adolescents

Global Action Plan to increase supply of pandemic influenza vaccines (GAP-II)

The real issues in vaccine safety

European Medicines Agency (EMA) 2009 Influenza Pandemic Evaluation

Narcolepsy following pandemic influenza A H1N1 2009 vaccination - ECDC update: the European Medicines Agency interim measures for Pandemrix

Swedish MPA publishes interim results of a cohort study assessing the risk of narcolepsy after vaccination with Pandemic influenza vaccine Pandemrix®

Reports of cases of narcolepsy and cataplexy in children and adolescents in Finland, Iceland, and Sweden

Influenza vaccine: selection of strains to be included in the seasonal vaccine for the Northern Hemisphere 2011-2012 – Early indications of seasonal vaccine effectiveness in Europe